« Vivox raises $7,800,000
Ambit Biosciences raises $49,300,000 »

Dicerna Pharmaceuticals raises $13,000,000

November 14, 2007
 VCA Theme: RNA Interference

Dicerna Pharmaceuticals Inc. raises $13,000,000.  The firm plans to commercialize RNAi-based drugs, which rely on RNA molecules to turn on and off disease-causing genes to treat patients.  Dicerna Pharmaceuticals is a developer of therapeutics for multiple therapeutic areas that is based on Dicer substrate technology, which involves an earlier step than is usually employed in the RNA interference process.